265 related articles for article (PubMed ID: 15205923)
21. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
Smets LA; Janssen M; Rutgers M; Ritzen K; Buttenhuis C
Int J Cancer; 1991 Jun; 48(4):609-15. PubMed ID: 2045205
[TBL] [Abstract][Full Text] [Related]
22. 99mTc-labeled MIBG derivatives: novel 99mTc complexes as myocardial imaging agents for sympathetic neurons.
Zhuang ZP; Kung MP; Mu M; Hou C; Kung HF
Bioconjug Chem; 1999; 10(2):159-68. PubMed ID: 10077463
[TBL] [Abstract][Full Text] [Related]
23. Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids.
Bayer M; Schmitt J; Dittmann H; Handgretinger R; Bruchelt G; Sauter AW
Nucl Med Biol; 2016 Sep; 43(9):543-551. PubMed ID: 27376201
[TBL] [Abstract][Full Text] [Related]
24. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
Zhang H; Huang R; Cheung NK; Guo H; Zanzonico PB; Thaler HT; Lewis JS; Blasberg RG
Clin Cancer Res; 2014 Apr; 20(8):2182-91. PubMed ID: 24573553
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
26. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
Smets LA; Loesberg C; Janssen M; Metwally EA; Huiskamp R
Cancer Res; 1989 Jun; 49(11):2941-4. PubMed ID: 2720653
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of phenylpiperazines as targeting agents for neuroblastoma.
Babich JW; Graham WA; Fischman AJ
Br J Cancer; 1996 Sep; 74(6):917-24. PubMed ID: 8826858
[TBL] [Abstract][Full Text] [Related]
28. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
[TBL] [Abstract][Full Text] [Related]
29. Pinhole imaging of 131I-metaiodobenzylguanidine (131I-MIBG) in an animal model of neuroblastoma.
Accorsi R; Morowitz MJ; Charron M; Maris JM
Pediatr Radiol; 2003 Oct; 33(10):688-92. PubMed ID: 12908090
[TBL] [Abstract][Full Text] [Related]
30. Meta-[123I]iodobenzylguanidine is selectively radiotoxic to neuroblastoma cells at concentrations that spare cells of haematopoietic lineage.
He Y; Das B; Baruchel S; Kumar P; Wiebe L; Reilly RM
Nucl Med Commun; 2004 Nov; 25(11):1125-30. PubMed ID: 15577592
[TBL] [Abstract][Full Text] [Related]
31. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
Vaidyanathan G; Zalutsky MR
Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
[TBL] [Abstract][Full Text] [Related]
32. Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.
Barrett JA; Joyal JL; Hillier SM; Maresca KP; Femia FJ; Kronauge JF; Boyd M; Mairs RJ; Babich JW
Cancer Biother Radiopharm; 2010 Jun; 25(3):299-308. PubMed ID: 20578835
[TBL] [Abstract][Full Text] [Related]
33. Biological evaluation of ring- and side-chain-substituted m-iodobenzylguanidine analogues.
Vaidyanathan G; Shankar S; Affleck DJ; Welsh PC; Slade SK; Zalutsky MR
Bioconjug Chem; 2001; 12(5):798-806. PubMed ID: 11562198
[TBL] [Abstract][Full Text] [Related]
34. Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice.
Taal BG; Hoefnagel C; Boot H; Valdés Olmos R; Rutgers M
Ann Oncol; 2000 Nov; 11(11):1437-43. PubMed ID: 11142484
[TBL] [Abstract][Full Text] [Related]
35. Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells.
Smets LA; Janssen M; Metwally E; Loesberg C
Biochem Pharmacol; 1990 Jun; 39(12):1959-64. PubMed ID: 2353937
[TBL] [Abstract][Full Text] [Related]
36. Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.
Vaidyanathan G; Affleck DJ; Zalutsky MR
J Nucl Med; 1995 Apr; 36(4):644-50. PubMed ID: 7699460
[TBL] [Abstract][Full Text] [Related]
37. Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells.
Iavarone A; Lasorella A; Servidei T; Riccardi R; Troncone L; Mastrangelo R
J Nucl Biol Med (1991); 1991; 35(4):186-90. PubMed ID: 1823815
[TBL] [Abstract][Full Text] [Related]
38. Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.
Armour A; Mairs RJ; Gaze MN; Wheldon TE
Br J Cancer; 1994 Sep; 70(3):445-8. PubMed ID: 8080728
[TBL] [Abstract][Full Text] [Related]
39. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
[TBL] [Abstract][Full Text] [Related]
40. Meta-[211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent.
Vaidyanathan G; Strickland DK; Zalutsky MR
Int J Cancer; 1994 Jun; 57(6):908-13. PubMed ID: 8206683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
